CIBC Global Technology F (CIB158)
9.871
+0.05 (+0.53%)
CAD |
May 20 2022
Returns Chart
Key Stats
Customize
Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
---|---|---|---|
1.17% | 338.70M | 0.00% | 133.0% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
4.622M | -13.83% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The fund seeks to provide long-term growth through capital appreciation by investing globally, primarily in companies that are involved in the development, application, production, or distribution of scientific and technology-based products and services. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | CIB496 |
Equity Style | Large Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Global Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | Canadian Imperial Bank of Commerce |
Prospectus Benchmark Index | |
MSCI World Information Tech CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Michal Marszal | 4.81 yrs |
Craig Jerusalim | 3.01 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
48
4.622M
-534.39M
Category Low
4.218B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 20, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 20, 2022.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Microsoft Corp | 9.22% | 260.59 | 3.18% |
Alphabet Inc Class A | 7.08% | 2229.15 | 2.34% |
Novartis AG
|
4.42% | -- | -- |
Mastercard Inc Class A | 4.25% | 348.74 | 3.74% |
UnitedHealth Group Inc | 4.19% | 492.09 | 1.31% |
Sanofi SA
|
4.06% | -- | -- |
Apple Inc | 3.92% | 143.06 | 3.98% |
Medtronic PLC | 3.87% | 104.24 | 1.67% |
CVS Health Corp | 3.87% | 95.55 | 0.65% |
Takeda Pharmaceutical Co Ltd
|
3.66% | -- | -- |
Basic Info
Investment Strategy | |
The fund seeks to provide long-term growth through capital appreciation by investing globally, primarily in companies that are involved in the development, application, production, or distribution of scientific and technology-based products and services. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | CIB496 |
Equity Style | Large Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Global Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | Canadian Imperial Bank of Commerce |
Prospectus Benchmark Index | |
MSCI World Information Tech CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Michal Marszal | 4.81 yrs |
Craig Jerusalim | 3.01 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (5-20-22) | 0.00% |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 0.0395 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of April 30, 2022
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 7/6/2020 |
Last Annual Report Date | 12/31/2021 |
Last Prospectus Date | -- |
Share Classes | |
CIB159 | -- |
CIB496 | Commission-based Advice |
CIB896 | -- |
Attributes | |
Enhanced Index Fund | No |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |